Skip to main content

Biomarker Matchmaking event 2021

16 Nov 2021
4:00 pm - 5:30 pm

Virtual

Inaugural Diagnostic Growth Hub Series: Biomarker Matchmaking

Book online

Less than 1% of proposed Biomarkers achieve clinical adoption and there is a wide gulf between those published in academic journals and those being translated onto scalable platforms that can be integrated into healthcare systems.

Earlier consideration of Biomarker platform should improve the efficiency and robustness of the research and enhance the likelihood of the end product being clinically useful. This therefore creates an argument for industry and academia to link up earlier to improve the quality of Biomarker research and ultimately improve success rates.

We believe that there are large number of platforms out there being developed by small to large companies which would be an excellent match for many Biomarker projects. The difficulty is how to link together the academics and these companies to see where goals and needs align.

A virtual matchmaking event where Biomarker academics from across London will present a short description of their research interests. This will be followed by short pitches from technology companies covering their platforms or services.

After the presentation there is an opportunity to link together researchers and industry representatives who could work together on current or future projects.

Introduction to MedCity by Neelam Patel, CEO MedCity

Opening address by Prof. George Hanna, Faculty of Medicine, Department of Surgery & Cancer, Imperial College London

Introduction to Biomarker Matchmaking by Dr. Christopher Peters, Faculty of Medicine, Department of Surgery & Cancer, Imperial College London

The event:

A virtual matchmaking event where senior Biomarker academics from across London will present a short description of their research interests. This will be followed by short pitches from technology companies covering their platforms or services.

Companies presenting:

HTG Molecular Diagnostics HTG Molecular

Sysmex Group SYSMEX

UltiVue Inc UltiVue Inc

Yourgene Health Yourgene Health

We would like to invite the academic community that work in this field to register and attend this event.

To register to attend please see here

Contact us
=